Clindamycin Phosphate Topical Solution USP recalled over manufacturing violations
- Recall date
- February 28, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- G & W Laboratories, Inc. recalls Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL…
- Recall number
- D-0519-2017
- FDA classification
- Class III
- Brand / firm
- G & W Laboratories, Inc.
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Clindamycin Phosphate Topical Solution USP, 1%, packaged in a) 30 mL applicator bottles (NDC 0472-0987-91) and b) 60 mL applicator bottles (NDC 0472-0987-92), Rx Only, Manufactured by: G&W Laboratories, Inc., 111 Coolidge Street, South Plainfield, NJ 07080; Distributed by: Actavis Mid Atlantic LLC, 1877 Kawai Road, Lincolnton, NC 28092.
Get recall alerts
Free email alert whenever G & W Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: G & W Laboratories, Inc.